Country Club Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $3.85M | Buy |
43,979
+957
| +2% | +$79.5K | 0.3% | 87 |
|
|
2021
Q3 | $3.57M | Buy |
43,022
+94
| +0.2% | +$8.46K | 0.31% | 86 |
|
|
2021
Q2 | $3.94M | Sell |
42,928
-96
| -0.2% | -$8.55K | 0.34% | 83 |
|
|
2021
Q1 | $3.74M | Buy |
43,024
+1,242
| +3% | +$111K | 0.35% | 82 |
|
|
2020
Q4 | $3.94M | Sell |
41,782
-3,000
| -7% | -$262K | 0.4% | 75 |
|
|
2020
Q3 | $3.89M | Sell |
44,782
-787
| -2% | -$68.2K | 0.44% | 70 |
|
|
2020
Q2 | $3.98M | Sell |
45,569
-2,884
| -6% | -$249K | 0.58% | 55 |
|
|
2020
Q1 | $3.97M | Sell |
48,453
-1,626
| -3% | -$145K | 0.54% | 63 |
|
|
2019
Q4 | $4.74M | Sell |
50,079
-505
| -1% | -$45.3K | 0.51% | 71 |
|
|
2019
Q3 | $4.42M | Sell |
50,584
-12,151
| -19% | -$1.09M | 0.5% | 71 |
|
|
2019
Q2 | $5.73M | Sell |
62,735
-8,623
| -12% | -$730K | 0.66% | 59 |
|
|
2019
Q1 | $6.15M | Sell |
71,358
-2,748
| -4% | -$221K | 0.72% | 52 |
|
|
2018
Q4 | $5.7M | Sell |
74,106
-1,563
| -2% | -$122K | 0.75% | 48 |
|
|
2018
Q3 | $5.84M | Buy |
75,669
+444
| +0.6% | +$32.8K | 0.68% | 54 |
|
|
2018
Q2 | $5.09M | Sell |
75,225
-2,200
| -3% | -$152K | 0.62% | 57 |
|
|
2018
Q1 | $5.61M | Buy |
77,425
+1,692
| +2% | +$129K | 0.69% | 47 |
|
|
2017
Q4 | $5.7M | Sell |
75,733
-5,354
| -7% | -$404K | 0.77% | 45 |
|
|
2017
Q3 | $6.24M | Sell |
81,087
-2,846
| -3% | -$215K | 0.85% | 43 |
|
|
2017
Q2 | $6.28M | Sell |
83,933
-1,621
| -2% | -$115K | 0.92% | 42 |
|
|
2017
Q1 | $5.69M | Buy |
85,554
+333
| +0.4% | +$22.2K | 0.78% | 48 |
|
|
2016
Q4 | $5.56M | Buy |
85,221
+1,056
| +1% | +$68.5K | 0.87% | 44 |
|
|
2016
Q3 | $5.96M | Buy |
84,165
+1,281
| +2% | +$93.3K | 0.84% | 45 |
|
|
2016
Q2 | $6.13M | Buy |
82,884
+2,122
| +3% | +$147K | 0.89% | 43 |
|
|
2016
Q1 | $5.24M | Sell |
80,762
-8,955
| -10% | -$609K | 0.79% | 47 |
|
|
2015
Q4 | $6.92M | Sell |
89,717
-1,027
| -1% | -$81.6K | 1.05% | 25 |
|
|
2015
Q3 | $7.47M | Buy |
90,744
+8,795
| +11% | +$783K | 1.15% | 21 |
|
|
2015
Q2 | $7.22M | Sell |
81,949
-3,123
| -4% | -$286K | 1.03% | 28 |
|
|
2015
Q1 | $7.52M | Sell |
85,072
-2,427
| -3% | -$215K | 1.06% | 33 |
|
|
2014
Q4 | $7.26M | Buy |
87,499
+3,266
| +4% | +$271K | 0.96% | 39 |
|
|
2014
Q3 | $7.11M | Sell |
84,233
-664
| -0.8% | -$53.7K | 0.95% | 36 |
|
|
2014
Q2 | $6.89M | Sell |
84,897
-1,703
| -2% | -$134K | 0.9% | 36 |
|
|
2014
Q1 | $6.6M | Buy |
86,600
+2,477
| +3% | +$180K | 0.93% | 34 |
|
|
2013
Q4 | $6.06M | Buy |
84,123
+2,684
| +3% | +$187K | 0.89% | 36 |
|
|
2013
Q3 | $5.6M | Buy |
81,439
+4,883
| +6% | +$323K | 0.89% | 38 |
|
|
2013
Q2 | $4.85M | Buy |
+76,556
| New | +$4.98M | 0.82% | 45 |
|
Other funds holding NVS
Country Club Trust's NVS Position: Q4 2021 in Review
Country Club Trust increased its Novartis (NVS) stake by 2.2% in Q4 2021, buying an estimated $79.5K and bringing the position to 43,979 shares worth $3.85M. The position accounts for 0.3% of the portfolio, ranked #87.
Country Club Trust first reported a position in NVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $7.52M in Q1 2015. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.
- Country Club Trust held 43,979 shares of Novartis worth $3.85M as of Q4 2021.
- Country Club Trust bought 957 Novartis shares in Q4 2021, an estimated $79.5K.
- Novartis made up 0.3% of Country Club Trust's portfolio in Q4 2021, its #87 holding.
- Country Club Trust first reported a position in Novartis in Q2 2013 and has held it in 35 quarters since.
- Country Club Trust's Novartis position peaked at $7.52M in Q1 2015.
- 1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.
Based on Country Club Trust's 13F filing for Q4 2021, filed 21 Jan 2022.